ANDA Sponsors May Need Extra Three Months To Avoid DMF-Related Delays

Under GDUFA, drug master files must pass a completeness assessment before they can be referenced in an ANDA. Sponsors should coordinate better with DMF holders to assure that FDA has adequate review time.